about
Rallybio Corp is a clinical-stage biotechnology company engaged in the development of therapeutic candidates for severe and rare diseases. It focuses on the treatment of conditions related to complement dysregulation and hematologic disorders. The co...
Read More
6.37
0.55
(9.45%)
109.2K
XNAS Volume
High volume+gain today
XNAS 26 Feb, 2026 2:34 PM (EST)
Board Meeting
The next board meeting for Rallybio Corp is on 06 Mar 2026 for the purpose of Rallybio Corp Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Rallybio Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..